Euglycemic diabetic ketoacidosis and COVID‐19 management in a term pregnant patient; a case report
Abstract In this case report, we report a Covid‐19 infected female patient with gestational diabetes mellitus with primary manifestation of ketoacidosis at term pregnancy and discuss the management challenges with euglycemia and a high ketone burden.
Main Authors: | Fatemeh Mohammadzade, Behnaz Khodabakhshi, Elahe Amiri, Amir Bigdeli, Fahimeh Abdollahi, Alireza Fatemi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-12-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.6705 |
Similar Items
-
Euglycemic diabetic ketoacidosis in pregnancy with COVID‐19: A case report and literature review
by: Sameena Wazir, et al.
Published: (2022-04-01) -
A case report of euglycemic ketoacidosis due to dapagliflozin treatment
by: Murat Çalapkulu, et al.
Published: (2021-03-01) -
Can euglycemic diabetic ketoacidosis caused by SGLT2 inhibitors be avoided in COVID-19 and other acute infections?
by: Georgios Pilianidis, et al.
Published: (2024-02-01) -
Euglycemic diabetic ketoacidosis associated with SGLT2 inhibitors: A systematic review and quantitative analysis
by: Siddhartha Dutta, et al.
Published: (2022-01-01) -
Managing Hospitalized Patients Taking SGLT2 Inhibitors: Reducing the Risk of Euglycemic Diabetic Ketoacidosis
by: Julia Selwyn, et al.
Published: (2023-02-01)